sameAs
P2176
A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot StudyA Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple MyelomaUse of Dexamethasone in Pediatric Asthma ExacerbationsBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaPomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaAutologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple MyelomaEvaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple MyelomaMLN9708 and Dexamethasone for High-Risk Smoldering Multiple MyelomaPhase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib MaintenanceBelatacept in Kidney Transplantation of Moderately Sensitized PatientsUARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionSIMPLE Chemotherapy for NK Lymphoma/LeukaemiaIxazomib Maintenance Study in Patients With AL AmyloidosisPre-emptive Scalp Infiltration With Dexamethasone Plus Ropivacaine for Postoperative Pain After CraniotomyEfficiency of IV Dexamethasone, Administered After a Lower Limb Blockade, on the Post Operative Pain in ChildrenTrial on the Effect of Isatuximab to Lenaliodomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)The Efficacy of Bendamustine, Gemcytabine, Dexamethasone (BGD) Salvage Chemotherapy With Autologous Stem Cell Transplantation (ASCT) Consolidation in Advanced Classical Hodgkin Lymphoma Patients Not Responding to ABVD TherapyEffect of Topical Tetracycline and Dexamethasone on Periodontal and Pulpal Regeneration of Replanted Avulsed TeethDexamethasone Versus Dexmedetomidine as Adjuvants for Nerve BlocksDexamethasone Added to Intensive Chemotherapy in Older Patients With Acute Myeloid Leukemia (AML)Dexamethasone Effect in the Reduction of Macular Thickness in Diabetic PatientsA Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationIontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in PediatricsAn Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma PatientsEffectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.Dexamethasone, Carfilzomib, & Nivolumab With Reovirus for Relapsed/Refractory Multiple MyelomaPhase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MMRole Of Dexamethasone In Induction Of LaborMidazolam Versus Dexamethasone-ondansetron in Preventing Postoperative Nausea-vomiting for Laparoscopic SurgeriesThe Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing ChemotherapyPomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in MexicansConventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel HypersensitivityCurcumin and Intravitreal Dexamethasone in Diabetic Macular EdemaCervical Interlaminar Versus Transforaminal Epidural Steroid InjectionEffect of Using Azithromycin Versus Placebo With Dexamethasone in Prevention of Post-spinal Nausea and Vomiting.High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative PhaseHigh vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After NephrectomyStudy of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.Sphenopalatine Ganglion Block Versus Occiptal Nerve Block in Treatment of Post Dural Puncture Headache
P4844
Q61862177-2B4A7A68-01AC-4691-BC24-D6748C95E2B2Q61862210-9FBBF7BB-2C3C-4E6B-B2BF-984150C6EDBCQ61862227-669E9ACE-BC7B-48DE-9C19-69E830B6BD01Q61864731-8CD972D6-21C2-45D2-A393-7FBB0F5D0FE1Q61864749-397A8BF3-019A-4FC0-8D6B-4427157EF42FQ61864779-4172FC75-43F5-4A68-B76A-09D705C63323Q61864815-CBBA349D-4511-44AF-BB49-75522407235AQ61864842-1691FCE0-CFAF-4B27-A2A0-4A26AFAD9E0CQ61864847-4EEF6E42-84DA-4AFB-AC1B-E2358027F4AAQ61864849-6A7C947E-F2A6-4106-A432-7A5C4E9E87E3Q61894370-92182884-C14B-4CC8-B2F9-A33F3E694504Q61894570-E7F6AB70-05C9-4648-BB28-56FC32ABA410Q61902425-8B3C907D-9F97-4DD3-9C75-D63065EEA479Q61902862-AC06765C-4EB4-4FEF-A35F-15783CEBA292Q61904680-2CEA1E0F-D6D5-485F-8C89-482757BD22BCQ61904688-5A6EC671-C05F-4B8A-A70F-604E8AD117D3Q61904718-71F045FE-D9F5-4C54-8C43-447DA161C6B5Q61904908-5C648DE9-F969-4001-BA83-5B56BED38C25Q61906744-DE5615D2-2DB5-4271-97C9-04089FA6BFFAQ61906839-3015BF5F-AAE0-42FA-BF87-F6EDCD58A992Q61906991-7A5522A1-AC96-48DF-8DB2-D68550EE28E4Q61907011-E03A7CE0-61B9-4728-8FE0-57C40D6B3B00Q61907040-6ECA4774-C5B9-482D-A799-AAAF699217EDQ61907170-AA16DAD8-CF0B-44A2-9836-7AA764B52AD5Q61907208-6DC937E3-E3CB-4686-92E7-D1AABB5AE657Q61907226-6A14D2C2-7729-4FCB-80C7-B51DDD8A18D3Q61907282-EF40DD26-7B17-4B3E-8D64-76F0F0A8FDABQ61907348-53169AEC-F105-4609-AFD6-0900DB7CED5BQ61907483-BBABB871-5CCD-4497-8188-605D2BF84519Q61907504-CB5B7F50-D5A2-4BAC-B305-ECF28BA9C475Q61907594-E6248A9D-329D-4141-914A-D54F226EA547Q61907614-AD34EE96-7FF0-4AF1-A8F5-39EF41B46370Q61907896-A6A3541D-B6F5-4BEB-8C9B-D63AFB87AA8FQ61907918-04245CEF-F8A1-462E-810C-98D27828F694Q61908764-8E4EA409-C2DE-462E-8163-71CAC90042B7Q61908832-C70AEC17-DA5F-461F-B858-861579B32439Q61909152-31A0D068-0C95-4FE9-A6F0-837F7B4F514EQ61909254-15848DC5-CC9E-4D9F-9220-45BB8D18BE5FQ61909412-A0406982-2C2B-45D6-87D9-65D8EFE2CB73Q61909616-5D46D255-2CF4-422D-BD6C-1536D2582C8A
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
deksametasonacetat
@nn
dexamethasone acetate
@en
type
label
deksametasonacetat
@nn
dexamethasone acetate
@en
altLabel
dexamethasone acetate anhydrous
@en
prefLabel
deksametasonacetat
@nn
dexamethasone acetate
@en
P592
P6366
P661
P662
P683
P2017
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC( ...... ([C@]1(C(=O)COC(=O)C)O)C)O)F)C
P2067
434.210467
P2175
P231
P232
P233
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C
P234
1S/C24H31FO6/c1-13-9-18-17-6-5 ...... ,18+,19+,21+,22+,23+,24+/m1/s1
P235
AKUJBENLRBOFTD-RPRRAYFGSA-N
P2566
100.013.315
P274
P3117
DTXSID8022901
P4964
splash10-00ds-3971000000-8fd86e4681958f0f751d
P592
CHEMBL1530428